Corrigendum: EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways.

Pan, Hongda; Pan, Jingxin; Song, Shibo; Ji, Lei; Lv, Hong; Yang, Zhangru.

Afiliação

Pan H; Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China.
Pan J; Department of Hematology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Song S; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Ji L; Department of Gastrointestinal Surgery, Beijing Hospital, Beijing, China.
Lv H; Department of Hematology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Yang Z; Department of Gastrointestinal Surgery, Beijing Hospital, Beijing, China.

Front Oncol ; 11: 670041, 2021.

Article em En | MEDLINE | ID: mdl-33898326